journal
https://read.qxmd.com/read/38555461/associations-of-triglyceride-glucose-tyg-index-with-chest-pain-incidence-and-mortality-among-the-u-s-population
#21
JOURNAL ARTICLE
Yao Zhao, Yu Gu, Bili Zhang
BACKGROUND: The triglyceride and glucose (TyG) index, a simple surrogate marker of insulin resistance, is related to cardiovascular disease. However, there is a lack of evidence for the relationship between the TyG index and chest pain. This study aimed to investigate the association of the TyG index with chest pain and to evaluate the relationship between the TyG index and all-cause mortality in participants with or without chest pain. METHODS: The present study utilized data from the 2001-2012 National Health and Nutrition Examination Survey (NHANES), employing a combination of cross-sectional and cohort study designs...
March 30, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38555454/risk-analysis-of-the-association-between-different-hemoglobin-glycation-index-and-poor-prognosis-in-critical-patients-with-coronary-heart-disease-a-study-based-on-the-mimic-iv-database
#22
JOURNAL ARTICLE
Xing Wei, Xinghua Chen, Zhipeng Zhang, Jing Wei, Ben Hu, Nv Long, Jun Feng, Chunmiao Luo
BACKGROUND: The hemoglobin glycation index (HGI) is the difference between the observed and predicted values of glycosylated hemoglobin (HbA1c), which is closely associated with a variety of poor prognoses. However, there are still no studies on the correlation between HGI and poor prognosis in patients with critical coronary artery disease. The purpose of this study was to analyze the correlation between HGI and all-cause mortality in patients with critical coronary artery disease using the MIMIC-IV database...
March 30, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38555442/effect-of-physical-activity-on-incident-atrial-fibrillation-in-individuals-with-varying-duration-of-diabetes-a-nationwide-population-study
#23
JOURNAL ARTICLE
JungMin Choi, So-Ryoung Lee, Eue-Keun Choi, Kyung-Yeon Lee, Hyo-Jeong Ahn, Soonil Kwon, Kyung-Do Han, Seil Oh, Gregory Y H Lip
BACKGROUND: Diabetes mellitus (DM) duration affects incident atrial fibrillation (AF) risk; the effect of physical activity on mitigating AF risk related to varying DM duration remains unknown. We assessed the effect of physical activity on incident AF in patients with DM with respect to known DM duration. METHODS: Patients with type 2 DM who underwent the Korean National Health Insurance Service health examination in 2015-2016 were grouped by DM duration: new onset and < 5, 5-9, and ≥ 10 years...
March 30, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38555431/elevated-levels-of-plasma-inactive-stromal-cell-derived-factor-1%C3%AE-predict-poor-long-term-outcomes-in-diabetic-patients-following-percutaneous-coronary-intervention
#24
JOURNAL ARTICLE
Yuichi Chikata, Hiroshi Iwata, Katsutoshi Miyosawa, Ryo Naito, Takuma Koike, Soshi Moriya, Hidetoshi Yasuda, Takehiro Funamizu, Shinichiro Doi, Hirohisa Endo, Hideki Wada, Manabu Ogita, Tomotaka Dohi, Takatoshi Kasai, Kikuo Isoda, Shinya Okazaki, Katsumi Miyauchi, Tohru Minamino
BACKGROUND: Since the complication of diabetes mellitus (DM) is a risk for adverse cardiovascular outcomes in patients with coronary artery disease (CAD), appropriate risk estimation is needed in diabetic patients following percutaneous coronary intervention (PCI). However, there is no useful biomarker to predict outcomes in this population. Although stromal cell derived factor-1α (SDF-1α), a circulating chemokine, was shown to have cardioprotective roles, the prognostic impact of SDF-1α in diabetic patients with CAD is yet to be fully elucidated...
March 30, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38553774/persistent-epigenetic-signals-propel-a-senescence-associated-secretory-phenotype-and-trained-innate-immunity-in-cd34-hematopoietic-stem-cells-from-diabetic-patients
#25
JOURNAL ARTICLE
Maria Cristina Vinci, Sarah Costantino, Giulia Damiano, Erica Rurali, Raffaella Rinaldi, Vera Vigorelli, Annalisa Sforza, Ermes Carulli, Sergio Pirola, Giorgio Mastroiacovo, Angela Raucci, Assam El-Osta, Francesco Paneni, Giulio Pompilio
BACKGROUND: Diabetes-induced trained immunity contributes to the development of atherosclerosis and its complications. This study aimed to investigate in humans whether epigenetic signals involved in immune cell activation and inflammation are initiated in hematopoietic stem/progenitor cells (HSPCs) and transferred to differentiated progeny. METHODS AND RESULTS: High glucose (HG)-exposure of cord blood (CB)-derived HSPCs induced a senescent-associated secretory phenotype (SASP) characterized by cell proliferation lowering, ROS production, telomere shortening, up-regulation of p21 and p27genes, upregulation of NFkB-p65 transcription factor and increased secretion of the inflammatory cytokines TNFα and IL6...
March 29, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38553758/lipidome-characterisation-and-sex-specific-differences-in-type-1-and-type-2-diabetes-mellitus
#26
JOURNAL ARTICLE
Maria Barranco-Altirriba, Núria Alonso, Ralf J M Weber, Gavin R Lloyd, Marta Hernandez, Oscar Yanes, Jordi Capellades, Andris Jankevics, Catherine Winder, Mireia Falguera, Josep Franch-Nadal, Warwick B Dunn, Alexandre Perera-Lluna, Esmeralda Castelblanco, Didac Mauricio
BACKGROUND: In this study, we evaluated the lipidome alterations caused by type 1 diabetes (T1D) and type 2 diabetes (T2D), by determining lipids significantly associated with diabetes overall and in both sexes, and lipids associated with the glycaemic state. METHODS: An untargeted lipidomic analysis was performed to measure the lipid profiles of 360 subjects (91 T1D, 91 T2D, 74 with prediabetes and 104 controls (CT)) without cardiovascular and/or chronic kidney disease...
March 29, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38553738/coronary-inflammation-based-on-pericoronary-adipose-tissue-attenuation-in-type-2-diabetic-mellitus-effect-of-diabetes-management
#27
JOURNAL ARTICLE
Yuankang Liu, Lisong Dai, Yue Dong, Cong Ma, Panpan Cheng, Cuiping Jiang, Hongli Liao, Ying Li, Xiang Wang, Xiangyang Xu
BACKGROUND: Coronary inflammation plays crucial role in type 2 diabetes mellitus (T2DM) induced cardiovascular complications. Both glucose-lowering drug interventions (GLDIS) and glycemic control (GC) status potentially correlate coronary inflammation, as indicated by changes in pericoronary adipose tissue (PCAT) attenuation, and thus influence cardiovascular risk. This study evaluated the impact of GLDIS and GC status on PCAT attenuation in T2DM patients. METHODS: This retrospective study collected clinical data and coronary computed tomography angiography (CCTA) images of 1,342 patients, including 547 T2DM patients and 795 non-T2DM patients in two tertiary hospitals...
March 29, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38528542/association-of-sodium-glucose-cotransporter-2-inhibitors-with-risk-of-major-adverse-cardiovascular-events-in-type-2-diabetes-patients-with-acute-coronary-syndrome-a-propensity-score%C3%A2-matched-analysis
#28
JOURNAL ARTICLE
Tao Liu, Zeyuan Fan, Bing Xiao, Chang He, Shicong Wang
BACKGROUND: This study aimed to investigate the association of sodium-glucose cotransporter 2 inhibitors (SGLT2i) use with cardiovascular (CV) clinical outcomes in type 2 diabetes (T2D) patients with acute coronary syndrome (ACS). METHODS: Data of T2D patients hospitalized for ACS at Civil Aviation General Hospital from January 2019 to December 2022 were collected. Based on SGLT2i use or not, patients were stratified as SGLT2i group and SGLT2i-free group. A 1:1 nearest-neighbor propensity score-matched (PSM) was performed to adjust for the confounding factors and facilitate the robust comparisons between groups...
March 25, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38504316/protective-effects-of-imeglimin-on-the-development-of-atherosclerosis-in-apoe-ko-mice-treated-with-stz
#29
JOURNAL ARTICLE
Junpei Sanada, Tomohiko Kimura, Masashi Shimoda, Yuichiro Iwamoto, Hideyuki Iwamoto, Kazunori Dan, Yoshiro Fushimi, Yukino Katakura, Yuka Nogami, Yoshiko Shirakiya, Yuki Yamasaki, Tomoko Ikeda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
BACKGROUND: Imeglimin is a new anti-diabetic drug which promotes insulin secretion from pancreatic β-cells and reduces insulin resistance in insulin target tissues. However, there have been no reports examining the possible anti-atherosclerotic effects of imeglimin. In this study, we investigated the possible anti-atherosclerotic effects of imeglimin using atherosclerosis model ApoE KO mice treated with streptozotocin (STZ). METHODS: ApoE KO mice were divided into three groups: the first group was a normoglycemic group without injecting STZ (non-DM group, n = 10)...
March 19, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38504284/cvot-summit-report-2023-new-cardiovascular-kidney-and-metabolic-outcomes
#30
LETTER
Oliver Schnell, Katharine Barnard-Kelly, Tadej Battelino, Antonio Ceriello, Helena Elding Larsson, Beatriz Fernández-Fernández, Thomas Forst, Juan-Pablo Frias, James R Gavin, Francesco Giorgino, Per-Henrik Groop, Hiddo J L Heerspink, Stephan Herzig, Michael Hummel, George Huntley, Mahmoud Ibrahim, Baruch Itzhak, Stephan Jacob, Linong Ji, Mikhail Kosiborod, Nebosja Lalic, Sofia Macieira, Rayaz A Malik, Boris Mankovsky, Nikolaus Marx, Chantal Mathieu, Timo D Müller, Kausik Ray, Helena W Rodbard, Peter Rossing, Lars Rydén, Petra-Maria Schumm-Draeger, Peter Schwarz, Jan Škrha, Frank Snoek, Frank Tacke, Bruce Taylor, Britta Tendal Jeppesen, Solomon Tesfaye, Pinar Topsever, Tina Vilsbøll, Xuefeng Yu, Eberhard Standl
The 9th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 30-December 1, 2023. This reference congress served as a platform for in-depth discussions and exchange on recently completed outcomes trials including dapagliflozin (DAPA-MI), semaglutide (SELECT and STEP-HFpEF) and bempedoic acid (CLEAR Outcomes), and the advances they represent in reducing the risk of major adverse cardiovascular events (MACE), improving metabolic outcomes, and treating obesity-related heart failure with preserved ejection fraction (HFpEF)...
March 19, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38500198/triglyceride-glucose-index-a-novel-evaluation-tool-for-all-cause-mortality-in-critically-ill-hemorrhagic-stroke-patients-a-retrospective-analysis-of-the-mimic-iv-database
#31
JOURNAL ARTICLE
Yongwei Huang, Zongping Li, Xiaoshuang Yin
BACKGROUND: Hemorrhagic stroke (HS), including non-traumatic intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH), constitutes a substantial proportion of cerebrovascular incidents, accounting for around 30% of stroke cases. The triglyceride-glucose index (TyG-i) represents a precise insulin resistance (IR) indicator, a crucial metabolic disturbance. Existing literature has demonstrated an association between TyG-i and all-cause mortality (ACM) among individuals suffering from ischemic stroke (IS)...
March 18, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38500197/prevalence-and-prognostic-significance-of-cardiac-autonomic-neuropathy-in-community-based-people-with-type-2-diabetes-the-fremantle-diabetes-study-phase-ii
#32
JOURNAL ARTICLE
Timothy M E Davis, Eva Tan, Wendy A Davis
BACKGROUND: There is a paucity of contemporary data on the prevalence and prognostic significance of cardiac autonomic neuropathy (CAN) from community-based cohorts with type 2 diabetes assessed using gold standard methods. The aim of this study was to assess these aspects of CAN in the longitudinal observational Fremantle Diabetes Study Phase II (FDS2). METHODS: FDS2 participants were screened at baseline using standardised cardiovascular reflex tests (CARTs) of heart rate variation during deep breathing, Valsalva manoeuvre and standing...
March 18, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38500162/postpartum-weight-retention-and-the-early-evolution-of-cardiovascular-risk-over-the-first-5-years-after-pregnancy
#33
JOURNAL ARTICLE
Caroline K Kramer, Chang Ye, Anthony J Hanley, Philip W Connelly, Mathew Sermer, Bernard Zinman, Ravi Retnakaran
BACKGROUND: The cumulative effect of postpartum weight retention from each pregnancy in a woman's life may contribute to her risk of ultimately developing type 2 diabetes and cardiovascular disease. However, there is limited direct evidence supporting this hypothesis. Thus, we sought to characterize the impact of postpartum weight retention on the trajectories of cardiovascular risk factors over the first 5-years after pregnancy. METHODS: In this prospective observational cohort study, 330 women (mean age 35...
March 18, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38500154/effectiveness-and-safety-of-the-combination-of-sodium-glucose-transport-protein-2-inhibitors-and-glucagon-like-peptide-1-receptor-agonists-in-patients-with-type-2-diabetes-mellitus-a-systematic-review-and-meta-analysis-of-observational-studies
#34
JOURNAL ARTICLE
Aftab Ahmad, Hani Sabbour
BACKGROUND: Randomized controlled trials and real-world studies suggest that combination therapy with sodium-glucose transport protein 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) is associated with improvement in fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), systolic blood pressure (SBP), body mass index (BMI), and total cholesterol levels. However, a systematic review of available real-world evidence may facilitate clinical decision-making in the real-world scenario...
March 18, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38500096/correction-cardiorenal-effectiveness-of-empagliflozin-vs-glucagon-like-peptide-1-receptor-agonists-final-year-results-from-the-emprise-study
#35
Phyo T Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J Wexler, Brendan M Everett, Robert J Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M Paik, Elisabetta Patorno
No abstract text is available yet for this article.
March 18, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38493287/telomere-length-as-biomarker-of-nutritional-therapy-for-prevention-of-type-2-diabetes-mellitus-development-in-patients-with-coronary-heart-disease-cordioprev-randomised-controlled-trial
#36
JOURNAL ARTICLE
Ana Ojeda-Rodriguez, Oriol A Rangel-Zuñiga, Antonio P Arenas-de Larriva, Francisco M Gutierrez-Mariscal, Jose D Torres-Peña, Juan L Romero-Cabrera, Alicia Podadera-Herreros, Helena García-Fernandez, Esther Porras-Pérez, Raul M Luque, Stefanos N Kales, Pablo Perez-Martinez, Javier Delgado-Lista, Elena M Yubero-Serrano, Jose Lopez-Miranda
BACKGROUND: Telomere Length (TL), a marker of cellular aging, holds promise as a biomarker to elucidate the molecular mechanism of diabetes. This study aimed to investigate whether shorter telomeres are associated with a higher risk of type 2 diabetes mellitus (T2DM) incidence in patients with coronary heart disease; and to determine whether the most suitable dietary patterns, particularly a Mediterranean diet or a low-fat diet, can mitigate the development of diabetes in these patients after a follow-up period of five years...
March 16, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38493102/hepatic-insulin-resistance-and-muscle-insulin-resistance-are-characterized-by-distinct-postprandial-plasma-metabolite-profiles-a-cross-sectional-study
#37
JOURNAL ARTICLE
Anouk Gijbels, Balázs Erdős, Inez Trouwborst, Kelly M Jardon, Michiel E Adriaens, Gijs H Goossens, Ellen E Blaak, Edith J M Feskens, Lydia A Afman
BACKGROUND: Tissue-specific insulin resistance (IR) predominantly in muscle (muscle IR) or liver (liver IR) has previously been linked to distinct fasting metabolite profiles, but postprandial metabolite profiles have not been investigated in tissue-specific IR yet. Given the importance of postprandial metabolic impairments in the pathophysiology of cardiometabolic diseases, we compared postprandial plasma metabolite profiles in response to a high-fat mixed meal between individuals with predominant muscle IR or liver IR...
March 16, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38486275/association-between-triglyceride-glucose-index-and-intracranial-extracranial-atherosclerotic-stenosis-findings-from-a-retrospective-study
#38
JOURNAL ARTICLE
Yu Xie, Kuan Cen, Bitang Dan, Li Zou, Lei Zhang, Renwei Zhang, Huagang Li, Qi Cai, Nadire Aiziretiaili, Zhenxing Liu, Yumin Liu
OBJECTIVE: The association of the triglyceride-glucose (TyG) index with intracranial atherosclerotic stenosis (ICAS) and extracranial atherosclerotic stenosis (ECAS) is unclear. This study aimed to investigate the relationship of TyG index with the distribution and severity of ICAS and ECAS. METHOD: Patients who underwent digital subtraction angiography (DSA) for evaluating ICAS/ECAS in Zhongnan Hospital of Wuhan University from January 2017 to October 2021 were retrospectively enrolled in our study...
March 14, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38486199/mct4-dependent-lactate-transport-a-novel-mechanism-for-cardiac-energy-metabolism-injury-and-inflammation-in-type-2-diabetes-mellitus
#39
JOURNAL ARTICLE
Xiu Mei Ma, Kang Geng, Peng Wang, Zongzhe Jiang, Betty Yuen-Kwan Law, Yong Xu
Diabetic cardiomyopathy (DCM) is a major contributor to mortality in diabetic patients, characterized by a multifaceted pathogenesis and limited therapeutic options. While lactate, a byproduct of glycolysis, is known to be significantly elevated in type 2 diabetes, its specific role in DCM remains uncertain. This study reveals an abnormal upregulation of monocarboxylate transporter 4 (MCT4) on the plasma membrane of cardiomyocytes in type 2 diabetes, leading to excessive lactate efflux from these cells. The disruption in lactate transport homeostasis perturbs the intracellular lactate-pyruvate balance in cardiomyocytes, resulting in oxidative stress and inflammatory responses that exacerbate myocardial damage...
March 14, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38468331/the-relative-and-combined-ability-of-stress-hyperglycemia-ratio-and-n-terminal-pro-b-type-natriuretic-peptide-to-predict-all-cause-mortality-in-diabetic-patients-with-multivessel-coronary-artery-disease
#40
JOURNAL ARTICLE
Le Wang, Chen Wang, Jia-Chun Lang, Rong-di Xu, Hong-Liang Cong, Jing-Xia Zhang, Yue-Cheng Hu, Ting-Ting Li, Chun-Wei Liu, Hua Yang, Wen-Yu Li
BACKGROUND: Stress hyperglycemia ratio (SHR) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are independently associated with increased mortality risk in diabetic patients with coronary artery disease (CAD). However, the role of these biomarkers in patients with diabetes and multivessel disease (MVD) remains unknown. The present study aimed to assess the relative and combined abilities of these biomarkers to predict all-cause mortality in patients with diabetes and MVD. METHODS: This study included 1148 diabetic patients with MVD who underwent coronary angiography at Tianjin Chest Hospital between January 2016 and December 2016...
March 11, 2024: Cardiovascular Diabetology
journal
journal
40195
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.